MicroRNA 10a Marks Regulatory T Cells

被引:89
|
作者
Jeker, Lukas T. [1 ,2 ]
Zhou, Xuyu [1 ,2 ]
Gershberg, Kseniya [1 ,2 ]
de Kouchkovsky, Dimitri [1 ,2 ]
Morar, Malika M. [1 ,2 ]
Stadthagen, Gustavo [3 ]
Lund, Anders H. [3 ]
Bluestone, Jeffrey A. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[3] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark
来源
PLOS ONE | 2012年 / 7卷 / 05期
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
TRANSCRIPTION FACTOR FOXP3; RETINOIC-ACID; REG-CELLS; IN-VIVO; DIFFERENTIATION; SPECIFICATION; GENERATION; RESPONSES; DICER; LEADS;
D O I
10.1371/journal.pone.0036684
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MicroRNAs (miRNAs) are crucial for regulatory T cell (Treg) stability and function. We report that microRNA-10a (miR-10a) is expressed in Tregs but not in other T cells including individual thymocyte subsets. Expression profiling in inbred mouse strains demonstrated that non-obese diabetic (NOD) mice with a genetic susceptibility for autoimmune diabetes have lower Treg-specific miR-10a expression than C57BL/6J autoimmune resistant mice. Inhibition of miR-10a expression in vitro leads to reduced FoxP3 expression levels and miR-10a expression is lower in unstable "exFoxP3" T cells. Unstable in vitro TGF-beta-induced, iTregs do not express miR-10a unless cultured in the presence of retinoic acid (RA) which has been associated with increased stability of iTreg, suggesting that miR-10a might play a role in stabilizing Treg. However, genetic ablation of miR-10a neither affected the number and phenotype of natural Treg nor the capacity of conventional T cells to induce FoxP3 in response to TGF beta, RA, or a combination of the two. Thus, miR-10a is selectively expressed in Treg but inhibition by antagomiRs or genetic ablation resulted in discordant effects on FoxP3.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] microRNA profiling of the GARP-FOXP3 regulatory circuit in human regulatory T cells
    Probst-Kepper, M.
    Hansen, W.
    Erck, C.
    Viegas, N.
    Kroeger, A.
    Buer, J.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 : 34 - 34
  • [12] T regulatory cells turn on T regulatory cells
    Scott, David W.
    BLOOD, 2009, 114 (19) : 3975 - 3976
  • [13] Intercellular transfer of microRNA between regulatory T cells and dendritic cells: a possible regulatory mechanism of dendritic cell function
    Smyth, L. A.
    Boardman, D.
    Lechler, R.
    Lombardi, G.
    IMMUNOLOGY, 2013, 140 : 24 - 24
  • [14] microRNA-17-92 Regulates IL-10 Production by Regulatory T Cells and Control of Experimental Autoimmune Encephalomyelitis
    de Kouchkovsky, Dimitri
    Esensten, Jonathan H.
    Rosenthal, Wendy L.
    Morar, Malika M.
    Bluestone, Jeffrey A.
    Jeker, Lukas T.
    JOURNAL OF IMMUNOLOGY, 2013, 191 (04): : 1594 - 1605
  • [15] The active form of CD44 marks functional suppressor activity in regulatory T cells
    Firan, M
    Dhillon, S
    Estess, P
    Siegelman, MH
    FASEB JOURNAL, 2005, 19 (04): : A390 - A390
  • [16] Uterine Regulatory T cells, IL-10 and Hypertension
    Nevers, Tania
    Kalkunte, Satyan
    Sharma, Surendra
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 66 : 88 - 92
  • [17] Preferential expression of miR-10a in regulatory T cells
    Takahashi, H.
    Kanno, Y.
    Nakayamada, S.
    Kuchen-Brandes, S.
    Casellas, R.
    O'Shea, J. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S93 - S93
  • [18] Interleukin 10 is a growth factor for a population of regulatory T cells
    Asseman, C
    Powrie, F
    GUT, 1998, 42 (02) : 157 - 158
  • [19] Regulatory T cells and IL-10 in allergic inflammation
    Hawrylowicz, CM
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (11): : 1459 - 1463
  • [20] Distinct cytokines balance the development of regulatory T cells and interleukin-10-producing regulatory B cells
    Holan, Vladimir
    Zajicova, Alena
    Javorkova, Eliska
    Trosan, Peter
    Chudickova, Milada
    Pavlikova, Michaela
    Krulova, Magdalena
    IMMUNOLOGY, 2014, 141 (04) : 577 - 586